Skip to main content
Clinical Trials/IRCT20190618043934N13
IRCT20190618043934N13RecruitingPhase 3

Comparison of the effectiveness of sertraline and Nortriptyline on anxiety and gastrointestinal symptoms in patients with irritable bowel syndrome: A double-blind clinical trial study

Birjand University of Medical Sciences0 sites192 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
192

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
All

Inclusion Criteria

  • Age 18 to 50 years
  • Patient consent to participate in the study

Exclusion Criteria

  • Lack of patient cooperation to participate in further study
  • History of gastrointestinal cancer
  • History of neurological disorder
  • Pregnancy and lactation
  • Bipolar or bipolar patients
  • Contraindications to the use of two drugs sertraline and nortriptyline
  • Use of antidepressants and anti-anxiety drugs
  • Allergy to prescription drugs
  • Co-occurring with serious physical illnesses such as heart disease, multiple sclerosis
  • Having a psychotic illness such as schizophrenia and related disorders
  • Substance abuse and substance abuse

Investigators

Similar Trials

Completed
Phase 3
Sertraline and Fluoxetin in Diabetic Patients with DepressioDiabetes Mellitus.Diabetes mellitus due to underlying condition
IRCT20150630022991N9Babol University of Medical Sciences40
Recruiting
Not Applicable
Comparison of therapeutic effect of sertraline and supportive psychotherapy in comparison with placebo in coronary heart disease patients with mild to moderate depressioCondition 1: Depression. Condition 2: Mild Depression. Condition 3: Moderate depression.F32 Depressive episode In typical mild, moderate, or severe depressive episodes, the patient suffers from lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, interest, and concentration is reduced, and marked tireF32.0 Mild depressive episode Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities.F32.1 Moderate depressive episode Four or more of the above symptoms are usually present and the patient is likely to have great difficulty in continuing with ordinary activities.
IRCT20171105037241N2Zahedan University of Medical Sciences90
Not yet recruiting
Phase 2
Comparison of the effect of sertraline and midodrine in improving blood pressure during hemodialysisHypotension of hemodialysis.Hypotension of hemodialysisI95.3
IRCT20100102002954N29Shahroud University of Medical Sciences82
Recruiting
Phase 2
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression level
IRCT20180425039418N4Zahedan University of Medical Sciences60
Completed
Phase 2
Comparison of two methods of treatment of sertraline in the treatment of premature ejaculatioPremature ejaculationPatients with premature ejaculation.
IRCT2013101415006N1niversity of Medical Sciences Iranian Army50